Inventor
JOHNSON YIU-NAM LAU
Inventor
US
Overview
Patents· 20 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes23%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations23%
C07KPeptides8%
C12NMicroorganisms or enzymes6%
C07DHeterocyclic compounds5%
Y02ATechnologies for adaptation to climate change5%
A61NElectrotherapy3%
C07BGeneral methods of organic chemistry3%
C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms3%
G01NInvestigating or analysing materials by determining their chemical or physical properties3%
PatentTitleYear
12,252,841Durable antimicrobial treatment of textile for use in healthcare environment202512,227,494Polymorphisms of HM30181 mesylate202512,213,955Compositions and methods for broad-spectrum antiviral therapy2025D1059702Automated disinfection device202512,144,856Compositions and methods for enhancing immune response to vaccination and improving vaccine production202412,090,029Devices and methods for enhancing immunogenicity to intradermal vaccination202411,963,942Oral taxane compositions and methods202411,931,417Methods of preparing a pegylated human IL-11 composition202411,898,180Compositions and methods for amino acid depletion therapy202411,826,425Compositions and methods for treatment of enterovirus infection202311,752,139Therapeutic combinations of orally administered irinotecan and a p-gp inhibitor for the treatment of cancer202311,752,156Compositions and methods for treating hyperproliferative skin disorders202311,739,089Acetamido-phenyltetrazole derivatives and methods of using the same202311,739,079Polymorphisms of HM30181 mesylate202311,629,367Systems and methods for production of recombinant IL-11 in yeast202311,497,750Methods of treating and/or preventing actinic keratosis202211,441,198Compositions and methods for providing a prognosis for influenza infection202211,389,442Therapeutic combinations of orally administered docetaxel and a P-gp inhibitor for the treatment of cancer202211,357,773Methods and compositions for enhancing immune response to vaccination202211,202,921Infant phototherapy device, method of use, and kit therefor2021Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2021–2025Based in US· patent location history
2022–2025Patents assigned to VERSITECH LTD (6)· patent assignee history
2022–2024Patents assigned to ATHENEX HK INNOVATIVE LTD (4)· patent assignee history
2022–2023Patents assigned to ATHENEX INC (2)· patent assignee history
2023–2025Patents assigned to ATHENEX R&D LLC (2)· patent assignee history
2023Based in CA· patent location history
2024–2025Patents assigned to HEALTH HOPE PHARMA LTD (2)· patent assignee history
2025Based in CN· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| VERSITECH LTD | 6 | 2022–2025 |
| ATHENEX HK INNOVATIVE LTD | 4 | 2022–2024 |
| ATHENEX INC | 2 | 2022–2023 |
| ATHENEX R&D LLC | 2 | 2023–2025 |
| HEALTH HOPE PHARMA LTD | 2 | 2024–2025 |
Locations
| Location | Patents | Span |
|---|---|---|
| US | 18 | 2021–2025 |
| CN | 1 | 2025 |
| CA | 1 | 2023 |